Status:
COMPLETED
Infection With Unknown Origin in the Emergency Department
Lead Sponsor:
University of Southern Denmark
Conditions:
Infection
Eligibility:
All Genders
18+ years
Brief Summary
Patients suspected with infection is one of the major groups, who are admitted to the Danish Emergency Departments (ED). Currently, there is no overall description of the distribution of these infecti...
Detailed Description
Bacteria resistant to antibiotics are associated with high antibiotic consumption and are identified by the World Health Organisation as a major public health threat. Despite efforts to optimize antib...
Eligibility Criteria
Inclusion
- Adults admitted to the ED will be invited to participate in the study, if the physician, receiving the patient, suspect the patient has an infection (e.g. indication for blood culture).
Exclusion
- If the attending physician considers that participation will delay a life-saving treatment or patient needs direct transfer to the intensive care unit.
- Admission within the last 14 days
- Verified COVID-19 disease within 14 days before admission
- Pregnant women
- Severe immunodeficiencies: Primary immunodeficiencies and secondary immunodeficiencies (HIV positive CD4 \<200, Patients receiving immunosuppressive treatment (ATC L04A), Corticosteroid treatment (\>20 mg/day prednisone or equivalent for \>14 days within the last 30 days), Chemotherapy within 30 days)
Key Trial Info
Start Date :
March 1 2021
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 1 2022
Estimated Enrollment :
966 Patients enrolled
Trial Details
Trial ID
NCT04661085
Start Date
March 1 2021
End Date
June 1 2022
Last Update
September 14 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hospital of Southern Jutland
Aabenraa, Denmark